ALAMEDA, Calif.–(BUSINESS WIRE)–Mekonos, Inc., a biotech platform company building the future of cell therapies on a chip, today announced the appointment of Benjamin Borgo, MBA, PhD, as chief operating officer. In this newly created role, he will be responsible for developing and implementing operational strategies to support the growth and…
Click here to view original post